Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT3 | Q9NTG7 | 10/20 | 0.83 |
| ▸ | KDM5A | P29375 | 7/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 2/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.73 |
| ▸ | KDM7A | Q6ZMT4 | 2/20 | 0.73 |
| ▸ | THRA | P10827 | 2/20 | 0.73 |
| ▸ | THRB | P10828 | 2/20 | 0.73 |
| ▸ | MLNR | O43193 | 1/20 | 0.73 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.73 |
| ▸ | PHF2 | O75151 | 1/20 | 0.73 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.73 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.73 |
| ▸ | FYN | P06241 | 1/20 | 0.73 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23682808 | 0.96 | SIRT3 (0.90) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL23682665 | 0.94 | SIRT3 (0.93) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL19077706 | 0.92 | KDM5A (0.77) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL23682805 | 0.91 | SIRT3 (1.00) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL15314912 | 0.90 | KDM5A (0.90) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL23683015 | 0.89 | KDM5A (0.89) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL23815659 | 0.87 | ABCB1 (0.90) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL9094300 | 0.86 | SIRT3 (0.88) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL25873319 | 0.86 | KDM5A (0.86) | SIRT3KDM5AALDH1A1TP53CYP3A4 | |
| SCHEMBL19895690 | 0.85 | KDM5A (0.85) | SIRT3KDM5AALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284629-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | NEDD4, UBQLN2, UBTF | SIRT3 4046/4885KDM5A 3009/4885ALDH1A1 4592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.